Increasing Diversity in Clinical Trials with PLATINUM Diversity: Outcomes with the Promus PREMIER™ Stent in Women and Minorities

Boston Scientific is launching an innovative registry aligned with its Close the Gap health equity initiative. The PLATINUM Diversity study will collect data from traditionally underrepresented patients using our Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System. This pioneering investigation will be the first of its kind to study how contemporary drug-eluting stent technology works in diverse populations.

Why Now? The Lack of Diversity in Data

The United States has always been a melting pot of cultures and ethnicities, and that diversity continues to grow at a rapid pace. However, there is very little clinical data that details the outcomes of medical devices in women and people of color.

According to the U.S. Centers for Disease Control and Prevention (CDC), cardiovascular disease is the leading cause of death for all Americans, including women and minorities.1 Despite this reality, women represent less than one-third of those in cardiovascular clinical trials conducted since 20062; while African Americans represent about 12 percent of the U.S. population, they comprise just five percent of patients in clinical trials.3

In an effort to lead the way in establishing best practices for collecting clinical data regarding medical devices in diverse patient populations, the PLATINUM Diversity study follows the guidance issued by the FDA for the collection of gender-specific data in clinical trials.

At Boston Scientific, we know that the more clinical evidence that is generated for patients who have historically been underrepresented in clinical trials, the better positioned we are to meet the needs of an ever-more diverse patient population.

About Close the Gap

Close the Gap is a Boston Scientific solution-oriented health equity initiative that aims to help everyone have access to the highest quality cardiovascular care regardless of race, ethnicity or gender. To learn more about Close the Gap, visit